Draft OIG Compliance Program For Pharmaceutical Manufacturers
September 2002 Department of Health and Human Services, Office of Inspector General Draft OIG Compliance Program For Pharmaceutical Manufacturers The federal Department of Health and Human Services Office of Inspector General (OIG) released a draft compliance program for pharmaceutical manufacturers on September 30, 2002, stating that many of the practices commonly used in the marketing and sale of prescription drugs could be in violation of federal fraud and abuse laws. Issued as a guidance to the pharmaceutical industry, the new standards specifically state that drug makers can not offer incentive payments or other "tangible benefits" to encourage or reward the . . .
